Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.
about
The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemiaPhase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.Management of adverse events associated with idelalisib treatment: expert panel opinion.mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.Risk of mTOR inhibitors induced severe pneumonitis in cancer patients: a meta-analysis of randomized controlled trials.The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges.Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging.Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models.A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus
P2860
Q26775506-8AB92DF6-9269-4DFB-A85B-F463E9710C9CQ35144264-A4B5FD37-3C9C-4D90-8EB8-FF928FA2A68FQ38366294-422EC441-48C0-4717-B984-B49F0B2CF6EBQ38603164-197CF3E5-095C-4BB9-9B26-56AAFFE0506EQ38882776-162383E8-3DB7-46D2-A6D6-15E685B474AFQ39096266-899A7AE0-6FAC-495E-A256-F2282D4E7DE3Q44953337-D09F82A8-2DB3-4F66-B616-F17DAAC4AE55Q47320024-E28CCCC1-049F-4713-A914-AE49B7BE2D87Q49486147-0D4EF8F1-0849-4331-AC1A-68BB2BEB53DAQ50898788-835EBCBB-4D62-4D4E-B98A-C3937BF08340Q53706060-16E03515-7CB9-451C-B1CE-779A1F529BD4Q54265850-79557A93-9B60-4508-A5BE-0D29E7ADC3C2Q56035477-EA806A22-130F-4E26-BD51-C7D0DB588DB7
P2860
Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-induced pneumonitis in ca ...... ghts into possible mechanisms.
@en
type
label
Drug-induced pneumonitis in ca ...... ghts into possible mechanisms.
@en
prefLabel
Drug-induced pneumonitis in ca ...... ghts into possible mechanisms.
@en
P2093
P2860
P50
P1476
Drug-induced pneumonitis in ca ...... ights into possible mechanisms
@en
P2093
Ignacio Duran
Jose Antonio Rodriguez-Portal
Konstantinos Papazisis
Peter-Jürgen Goebell
P2860
P304
P356
10.1517/14740338.2014.888056
P407
P577
2014-02-11T00:00:00Z